Nomination Committee change in Diagonal Bio (publ.)

, ,
Diagonal Bio announces a change the Nomination Committee for the Annual General Meeting (AGM) on May 20, 2025.According to the instructions for the Nomination Committee adopted by the AGM in 2024, the Nomination Committee for the Diagonal Bios…

Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 2025

, , ,
Today, January 17, 2025, an Extraordinary General Meeting was held in Diagonal Bio AB. A summary of the adopted resolutions follows below. Resolution on reduction of the share capital for allocation to non-restricted equity The general…

Diagonal Bio expands its testing panel for horses with EHV-5 detection

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces the expansion of its equine diagnostic testing panel to include the detection of Equine Herpesvirus type 5 (EHV-5), following the recommendation of Daniel Redén –…

Kallelse till extra bolagsstämma i Diagonal Bio AB

, , ,
Aktieägarna i Diagonal Bio AB, org.nr 559248-8984, kallas härmed till extra bolagsstämma fredagen den 17 januari 2025 kl. 13.00 på Medicon Village, i huvudbyggnaden The Spark, Scheeletorget 1, Lund.Rätt att delta och…

The Board of Directors of Diagonal Bio AB resolves on a directed issue of units and a rights issue of units to focus on validation of LAMPlify®’s commercial interest

, , , ,
Board of Directors of Diagonal Bio AB (”Diagonal Bio” or the ”Company”) has today resolved on a directed issue of units consisting of shares and consideration free warrants of series TO 2, of initially approximately SEK…

Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Daniel Redén, a renowned horse trainer at StallZet, has entered into a partnership with Diagonal Bio and will act as a marketing partner for the Company to enhance…

Renowned horse race jockey and trainer conducts pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that one of Sweden’s most accomplished horse race trainers, Madeleine Smith, has initiated a six-month pilot test of LAMPlify®.  The pilot test will focus on enhancing…

Nomination Committee appointed for Diagonal Bio

, ,
Diagonal Bio today announces that the Nomination Committee has been appointed in preparation for the Annual General Meeting (AGM) on May 20, 2025.According to the instruction for the Nomination Committee adopted by the AGM in 2024, the Nomination…

Valberedning utsedd i Diagonal Bio AB (publ) inför årsstämman 2025

, ,
I enlighet med de principer för inrättande av valberedning som tidigare beslutats på årsstämman 2024, har följande valberedning utsetts för Diagonal Bio AB (publ.) inför årsstämman den 20…

Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Kolgjini Stables (Stall Kolgjini), founded by renowned harness racer Lutfi Kolgjini, to conduct a three-month pilot test. Kolgjini Stables is a Swedish stable…